Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate /
Saved in:
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Format: | Government Document Electronic eBook |
| Language: | English |
| Published: |
[Washington, District of Columbia] :
United States Government Accountability Office,
[2020]
|
| Series: | Testimony ;
GAO-2-626T. COVID-19: pandemics past and present. |
| Subjects: | |
| Online Access: | CONNECT |
MARC
| LEADER | 00000nam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | mig00005803140 | ||
| 006 | m fo d f | ||
| 007 | cr bn nnnauuuu | ||
| 008 | 210104s2020 dcuab ob f000 0 eng d | ||
| 005 | 20231102134101.2 | ||
| 035 | |a 1heinccn00955349 | ||
| 040 | |a NjRocCCS |b eng |e rda |c NjRocCCS | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a KF3885 |b .U55 2020 | |
| 074 | |a 0546-D-01 (online) | ||
| 086 | 0 | |a GA 1.5/2:GAO-20-626 T | |
| 110 | 1 | |a United States. |b Government Accountability Office, |e author, |e issuing body. | |
| 245 | 1 | 0 | |a Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : |b testimony before the Committee on Finance, U.S. Senate / |c statement of Mary Denigan-Macauley. |
| 264 | 1 | |a [Washington, District of Columbia] : |b United States Government Accountability Office, |c [2020] | |
| 264 | 2 | |a [Getzville, New York] : |b William S. Hein & Company, |c [2020] | |
| 300 | |a 1 online resource (26 pages) : |b illustrations, maps. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Testimony ; |v GAO-20-626-T | |
| 490 | 1 | |a HeinOnline COVID-19: pandemics past and present | |
| 590 | |a Cassidy Cataloguing Services, Inc. | ||
| 500 | |a "For release on delivery, expected at 2:30 p.m. ET, Tuesday, June 2, 2020." | ||
| 504 | |a Includes bibliographical references. | ||
| 588 | |a Description based on PDF title page, viewed January 4, 2021. | ||
| 610 | 1 | 0 | |a United States. |b Food and Drug Administration |x Rules and practice. |
| 650 | 0 | |a COVID-19 (Disease) |x Treatment |z United States. | |
| 650 | 0 | |a Drugs |x Inspection |z United States. | |
| 650 | 0 | |a Drugs |z United States |x Safety measures |x Evaluation. | |
| 650 | 0 | |a Pharmaceutical industry |x Quality control |x Evaluation. | |
| 650 | 0 | |a Drugs |x Safety regulations |z United States |x Evaluation. | |
| 650 | 0 | |a Drug reimportation |z United States |x Evaluation. | |
| 650 | 0 | |a Imports |z United States |x Safety measures |x Evaluation. | |
| 700 | 1 | |a Denigan-Macauley, Mary, |e author. | |
| 710 | 1 | |a United States. |b Congress. |b Senate. |b Committee on Finance, |e sponsoring body. | |
| 730 | 0 | |a HeinOnline Records | |
| 830 | 0 | |a Testimony ; |v GAO-2-626T. | |
| 830 | 0 | |a COVID-19: pandemics past and present. | |
| 856 | 4 | 0 | |3 HeinOnline COVID-19 |u https://ezproxy.mtsu.edu/login?url=https://www.heinonline.org/HOL/Page?handle=hein.gao/gaobaebej0001&id=1&size=2&collection=covidcol&index=alpha/D_covidcol |z CONNECT |t 0 |
| 907 | |a 5219979 |b 06-13-21 |c 02-02-21 | ||
| 998 | |a wi |b 02-03-21 |c m |d z |e - |f eng |g dcu |h 0 |i 2 | ||
| 999 | f | f | |i 81618dd1-77dc-4e61-96c2-4dfa30b4e5bd |s 6b2feae1-4eb0-4f5f-a4a8-49e4fa882555 |t 0 |
| 952 | f | f | |a Middle Tennessee State University |b Main |c James E. Walker Library |d Electronic Resources |t 0 |e KF3885 .U55 2020 |h Library of Congress classification |
